YMAB - Y-mAbs Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.71
DETAILS
HIGH:
$24.00
LOW:
$8.60
MEDIAN:
$8.60
CONSENSUS:
$12.71
UPSIDE:
47.62%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 82.6% |
| EBIT Margin | -35.6% |
| EBITDA Margin | -35.0% |
| Operating Margin | -35.6% |
| Pretax Margin | -34.0% |
| Cont. Ops Margin | -33.8% |
| Net Margin | -33.8% |
| Bottom Line Margin | -33.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.16 |
| Quick Ratio | 3.85 |
| Solvency Ratio | -1.044 |
| Cash Ratio | 2.84 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-11.70
Peers avg: 15.6
|
| PEG Ratio | -0.32 |
| Forward PEG | -0.32 |
| Price/Book | 3.77 |
| Price/Sales | 3.96 |
| Price/FCF | -22.09 |
| Price/Op Cash Flow | -22.09 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0068 |
| Debt/Equity | 0.0089 |
| Debt/Capital | 0.0088 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.30 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.06 |
| Operating Cash Flow Ratio | -0.663 |
| Operating Cash Flow/Sales | -17.9% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -19.16 |
| Capital Expenditure Coverage | 0.00 |
| Dividend + Capital Expenditure Coverage | 0.00 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.98 |
| EPS | -0.669 |
| Debt/Share | 0.0185 |
| Cash/Share | 1.52 |
| Book Value/Share | 2.08 |
| Tangible BV/Share | 2.02 |
| Equity/Share | 2.08 |
| Operating Cash Flow/Share | -0.354 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.354 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.995 |
| Earnings Before Tax/EBIT | 0.955 |
| Price/Fair Value | 3.77 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.5% |
| Enterprise Value Multiple | -9.15 |